Paper Details
- Home
- Paper Details
Do the old psychostimulant drugs have a role in managing treatment-resistant depression?
Author: BrotchieH, ParkerG
Original Abstract of the Article :
OBJECTIVE: As the authors have observed clinical benefit from the psychostimulants methylphenidate and dexamphetamine for treating resistant melancholic and bipolar depression, those drugs were evaluated in a consecutively recruited sample of 50 such patients. METHOD: Patients (27 bipolar, 23 unipo...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1111/j.1600-0447.2009.01434.x
データ提供:米国国立医学図書館(NLM)
Rethinking Psychostimulants: A Potential Role in Treatment-Resistant Depression
The field of [Depression Treatment] is continuously seeking new and effective ways to address this prevalent condition. This study explores the potential of [Psychostimulants, such as Methylphenidate and Dexamphetamine] in treating [Treatment-Resistant Depression]. The researchers observed clinical benefit from these drugs in patients with [melancholic and bipolar depression] who had not responded to conventional antidepressants. They conducted a [consecutive case series] to evaluate the efficacy of psychostimulants in this population. Their findings suggest that [psychostimulants may offer a promising treatment option for patients with treatment-resistant depression, particularly those with melancholic or bipolar features].
A New Perspective on Depression Treatment
This study challenges conventional thinking about the role of psychostimulants in depression treatment, offering a potentially valuable new avenue for managing this condition. The findings highlight the importance of exploring alternative treatment options for patients who have not responded to conventional therapies.
Expanding the Therapeutic Landscape for Depression
The desert of depression research is vast and complex, with many unanswered questions. This study offers a new perspective on the potential of psychostimulants in treating this challenging condition, expanding the therapeutic landscape for patients who have not found relief from traditional approaches.
Dr. Camel's Conclusion
This study explores the potential of psychostimulants in treating treatment-resistant depression, offering a potentially valuable new avenue for managing this condition and expanding the therapeutic landscape for patients who have not found relief from traditional approaches.
Date :
- Date Completed 2010-07-21
- Date Revised 2013-11-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.